Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder

被引：175
|
作者：
Cortese, Samuele [1 ,2 ,3 ]
机构：
[1] Univ Southampton, Ctr Innovat Mental Hlth, Sch Psychol,Fac Environm & Life Sci, Clin & Expt Sci CNS & Psychiat,Fac Med, Southampton, Hants, England
[2] Univ Nottingham, Sch Med, Inst Mental Hlth, Div Psychiat & Appl Psychol, Nottingham, England
[3] NYU, Grossman Sch Med, Dept Child & Adolescent Psychiat, New York, NY USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 383卷 / 11期
关键词：
DEFICIT/HYPERACTIVITY DISORDER; STIMULANT-MEDICATION; ADHD; CHILDREN; DISCONTINUATION; METAANALYSIS;
D O I：
10.1056/NEJMra1917069
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Amphetamines and methylphenidate and, less often, nonstimulants (atomoxetine, clonidine, and guanfacine) are used to treat ADHD. Inattentiveness and restlessness are improved more than quality-of-life measures in short-term trials.
引用
收藏
页码：1050 / 1056
页数：7
相关论文
共 50 条
  • [31] Medication for Attention Deficit-Hyperactivity Disorder and Criminality REPLY
    Lichtenstein, Paul
    Larsson, Henrik
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (08): : 776 - 776
  • [32] Utility of EEG on attention deficit-hyperactivity disorder (ADHD)
    Ben Mahmoud, Mariem
    Ben Ali, Nadia
    Fray, Saloua
    Jamoussi, Hela
    Chebbi, Slim
    Fredj, Mohamed
    EPILEPSY & BEHAVIOR, 2021, 114
  • [33] Attention Deficit-Hyperactivity Disorder and Month of School Enrollment
    Syn, Nicholas L.
    Law, Evelyn
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (07): : 692 - 692
  • [34] Attention Deficit-Hyperactivity Disorder and Month of School Enrollment
    Layton, Timothy J.
    Barnett, Michael L.
    Hicks, Tanner R.
    Jena, Anupam B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2122 - 2130
  • [35] Attention deficit-hyperactivity disorder in children with burn injuries
    Badger, Karen
    Anderson, Lori
    Kagan, Richard J.
    JOURNAL OF BURN CARE & RESEARCH, 2008, 29 (05): : 724 - 729
  • [36] Attention deficit-hyperactivity disorder and enuresis in children and adolescents
    Zavadenko, N. N.
    Kolobova, N. M.
    Suvorinova, N. Yu.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (02) : 50 - 55
  • [37] Attention deficit-hyperactivity disorder: biological causes and treatments
    Curran, S
    Taylor, EA
    CURRENT OPINION IN PSYCHIATRY, 2000, 13 (04) : 397 - 402
  • [38] MORE FREQUENT DIAGNOSIS OF ATTENTION DEFICIT-HYPERACTIVITY DISORDER
    SWANSON, JM
    LERNER, M
    WILLIAMS, L
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (14): : 944 - 944
  • [39] Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder
    Fariba Arabgol
    Leily Panaghi
    Paria Hebrani
    European Child & Adolescent Psychiatry, 2009, 18 : 53 - 59
  • [40] A pharmacokinetic evaluation of oral edivoxetine hydrochloride for the treatment of attention deficit-hyperactivity disorder
    Markowitz, John S.
    Brinda, Bryan J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (09) : 1289 - 1299
12345